MAHA activists and bipartisan House members seek to remove pesticide shield from farm bill
Updated
Updated · POLITICO · Apr 26
MAHA activists and bipartisan House members seek to remove pesticide shield from farm bill
6 articles · Updated · POLITICO · Apr 26
Republican Rep. Anna Paulina Luna and Democrat Rep. Chellie Pingree lead efforts to strip the provision, with multiple amendments introduced and a MAHA rally planned outside the Supreme Court.
The farm bill faces additional hurdles over state livestock regulations and ethanol sales, with GOP leaders weighing whether to allow amendment votes to secure enough support for passage.
House Agriculture Chair G.T. Thompson argues the bill is vital for farmers, while divisions over pesticide liability, state authority, and biofuels threaten its progress as the Supreme Court reviews glyphosate-related lawsuits.
How will the Supreme Court's upcoming pesticide ruling influence the Farm Bill debate?
Beyond pesticides and livestock, what other major changes are hidden in the Farm Bill?
Will federal law override California's rules on how farm animals are raised?
What happens to food prices if farmers' access to key pesticides changes?
Can a product be safe by federal standards but unsafe by state law?
With conflicting science, who decides if a chemical is safe for public use?
The 2026 Farm Bill’s Pesticide Liability Shield: Legal Immunity, State Preemption, and Public Health Risks
Overview
In April 2026, the House Agriculture Committee passed the 2026 Farm Bill, which includes a controversial pesticide liability shield granting manufacturers legal immunity and blocking stricter state regulations. This provision, strongly supported by Bayer to limit costly glyphosate lawsuits, sparked bipartisan opposition and led Representatives Pingree and Massie to introduce an amendment to remove the shield, which failed in committee. The shield has intensified divisions within the Republican Party and faces further challenges in the Senate, where leadership plans to exclude or weaken it to secure bipartisan support. Meanwhile, states like California may legally challenge the federal preemption, highlighting ongoing tensions over public health, corporate accountability, and states' rights.